Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Related Research Data
One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles
Source:
Elsevier BV
Measurement of Poly(ethylene glycol) by Cell-Based Anti-poly(ethylene glycol) ELISA
Source:
American Chemical Society (ACS)
Nanoparticle Delivery of Cancer Drugs
Source:
Annual Reviews
Nanoparticles in cancer therapy and diagnosis
Source:
Elsevier BV
Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system
Source:
Elsevier BV
Antibody–drug conjugates: current status and future directions
Source:
Elsevier BV
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Source:
Royal Society of Chemistry (RSC)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Source:
Springer Science and Business Media LLC
Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
Source:
American Chemical Society (ACS)
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Source:
Springer Nature
The Clathrin-Mediated Endocytic Pathway Participates in dsRNA-Induced IFN- Production
Source:
The American Association of Immunologists
Nanoparticles in cancer therapy and diagnosis
Source:
Elsevier BV
Determination of total and unbound docetaxel in plasma by ultrafiltration and UPLC-MS/MS: application to pharmacokinetic studies
Source:
Springer Nature
Timeline: Chemotherapy and the war on cancer.
Source:
Springer Science and Business Media LLC
Nanoparticle therapeutics: an emerging treatment modality for cancer
Source:
Springer Science and Business Media LLC
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
Source:
Proceedings of the National Academy of Sciences
The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes
Source:
Elsevier BV
Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages
Source:
Beilstein-Institut zur Förderung der Chemischen Wissenschaften
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Source:
Taylor & Francis
Stable Docking of Neutralizing Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Monoclonal Antibodies 2F5 and 4E10 Is Dependent on the Membrane Immersion Depth of Their Epitope Regions
Source:
American Society for Microbiology
Effect of Polyethyleneglycol (PEG) Chain on Cell Uptake of PEG-Modified Liposomes
Source:
Informa UK Limited
Search for inhibitors of endocytosis
Source:
Informa UK Limited
Susceptibility vs. functionality of critical quality attributes
Source:
Informa UK Limited
The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments
Source:
American Society for Cell Biology (ASCB)
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
Source:
Royal Society of Chemistry (RSC)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Source:
Elsevier BV
Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation
Source:
Springer Science and Business Media LLC
Dynasore, a Cell-Permeable Inhibitor of Dynamin
Source:
Elsevier BV
Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption
Source:
Elsevier BV
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Source:
Taylor & Francis
Linking provided by
